GN Store Nord A/S (GNNDY)
OTCMKTS · Delayed Price · Currency is USD
55.70
-0.41 (-0.73%)
Sep 18, 2025, 9:30 AM EDT
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of $2.73 billion as of September 18, 2025. Its market cap has decreased by -17.62% in one year.
Market Cap
2.73B
Enterprise Value
4.43B
Revenue
2.73B
Ranking
n/a
PE Ratio
19.87
Stock Price
$55.70
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 53.13M to 2.73B, an increase of 5,046.62%. That is a compound annual growth rate of 12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 2.73B | 0.89% |
| Dec 30, 2024 | 2.71B | -26.91% |
| Dec 29, 2023 | 3.71B | 26.26% |
| Dec 30, 2022 | 2.94B | -63.28% |
| Dec 30, 2021 | 8.00B | -22.82% |
| Dec 30, 2020 | 10.36B | 70.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 373.88M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |